Wednesday, February 5, 2025

Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

from Top Health News -- ScienceDaily https://ift.tt/3gw2jKD
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

More than 1,000 genetic switches reveal why female immunity is different

More than 1,000 genetic switches behave differently in male and female immune cells, helping explain why women are much more vulnerable to a...